Gregory Schwartz, PhD, an RPB Career Development Award recipient, and his research collaborators at Northwestern University School of Medicine, recently published important discoveries related to blood vessel regulation in the journal Neuron. They identified nitric oxide-releasing amacrine cells as critical to blood vessel regulation in the retina and beyond.
The findings could impact diseases involving blood flow, such as diabetic retinopathy (DR). By detecting damage to nitric oxide-releasing amacrine cells, DR could potentially be diagnosed years earlier than is currently possible—before damage occurs. The knowledge gained through this research could even lead to new options for stroke treatment.
November 27, 2018
Research to Prevent Blindness and Castle Biosciences are partnering to provide new opportunities for medical students to pursue ocular cancer research.
Research to Prevent Blindness and Aerie Pharmaceuticals are partnering to provide grant opportunities to support novel research in glaucoma.
RPB and the AOCOO-HNS Foundation are launching a multi-year partnership to provide funding to increase research opportunities in vision science for students of osteopathic medicine.
This ground-breaking research accomplishment will open new doors for research on neurodegenerative diseases like AMD.
The awards offered cover a wide variety of topics in vision science, including glaucoma, age-related macular degeneration, ocular cancer, amblyopia, low vision, and many more.
RPB grantees provide expert insight on geographic atrophy and dry AMD as part of the "Lunch & Learn" series.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |